132 related articles for article (PubMed ID: 15918449)
1. Coagulation management of a patient with factor V Leiden mutation, lupus anticoagulant, and activated protein C resistance: a case report.
Stammers AH; Dorion RP; Trowbridge C; Yen B; Klayman M; Murdock JD; Woods E; Gilbert C
Perfusion; 2005 Mar; 20(2):115-20. PubMed ID: 15918449
[TBL] [Abstract][Full Text] [Related]
2. [Anesthetic management for a patient with heparin-induced thrombocytopenia (HIT) undergoing off-pump coronary bypass surgery using argatroban, a direct thrombin inhibitor].
Saito T; Uchida E; Saima S; Chiba A; Arai T; Okuda Y
Masui; 2009 Sep; 58(9):1169-71. PubMed ID: 19764444
[TBL] [Abstract][Full Text] [Related]
3. Lupus anticoagulant and off-pump coronary bypass: dilemma of anticoagulation.
Maddali MM; Albahrani MJ
Asian Cardiovasc Thorac Ann; 2007 Jun; 15(3):246-8. PubMed ID: 17540998
[TBL] [Abstract][Full Text] [Related]
4. [Intraoperative management for a patient with heparin-induced thrombocytopenia (HIT) undergoing off-pump coronary bypass surgery using argatroban, a direct thrombin inhibitor].
Ohno H; Yokoi M
Masui; 2002 Jan; 51(1):30-3. PubMed ID: 11840659
[TBL] [Abstract][Full Text] [Related]
5. Heparin induced thrombocytopenia in a patient with factor V Leiden following cardiac surgery.
Chaubey S; Davidson SJ; Desouza AC
Interact Cardiovasc Thorac Surg; 2009 Dec; 9(6):1023-5. PubMed ID: 19783545
[TBL] [Abstract][Full Text] [Related]
6. Determination of activated protein C resistance in anticoagulated and lupus positive patients.
Ivey LM; Thom JY; Ivey JG; Baker RI
Blood Coagul Fibrinolysis; 2000 Jul; 11(5):439-45. PubMed ID: 10937805
[TBL] [Abstract][Full Text] [Related]
7. The role of natural anticoagulant deficiencies and factor V Leiden in the development of idiopathic portal vein thrombosis.
Egesel T; Büyükasik Y; Dündar SV; Gürgey A; Kirazli S; Bayraktar Y
J Clin Gastroenterol; 2000 Jan; 30(1):66-71. PubMed ID: 10636214
[TBL] [Abstract][Full Text] [Related]
8. Fondaparinux therapy in a hemodialysis patient with heparin-induced thrombocytopenia type II.
Wellborn-Kim JJ; Mitchell GA; Terneus WF; Stowe CL; Malias MA; Sparkman GM; Hanson GW
Am J Health Syst Pharm; 2010 Jul; 67(13):1075-9. PubMed ID: 20554593
[TBL] [Abstract][Full Text] [Related]
9. Coexistence of factor V Leiden and primary antiphospholipid syndrome: a patient with recurrent myocardial infarctions and thrombocytopenia.
Schütt M; Klüter H; Wiedemann GJ; Richardt G
Z Kardiol; 2000 Dec; 89(12):1067-71. PubMed ID: 11201021
[TBL] [Abstract][Full Text] [Related]
10. Heparin-induced thrombocytopenia in coronary bypass surgery.
Arnoletti JP; Whitman GJ
Ann Thorac Surg; 1999 Aug; 68(2):576-8. PubMed ID: 10475440
[TBL] [Abstract][Full Text] [Related]
11. [Use of argatroban as a substitute for heparin in a patient with suspected HIT type II undergoing carotid endarterectomy].
Fujisawa M; Nakazawa K; Makita K
Masui; 2004 Sep; 53(9):1057-60. PubMed ID: 15500112
[TBL] [Abstract][Full Text] [Related]
12. Use of argatroban as a procedural and bridging anticoagulant in a patient undergoing carotid endarterectomy with concomitant atrial fibrillation.
Nanda MM; Kauflin MJ; Jain PG; Yannetta JC
Ann Pharmacother; 2011 Mar; 45(3):e16. PubMed ID: 21386022
[TBL] [Abstract][Full Text] [Related]
13. Argatroban as a primary or secondary postoperative anticoagulant in patients implanted with ventricular assist devices.
Samuels LE; Kohout J; Casanova-Ghosh E; Hagan K; Garwood P; Ferdinand F; Goldman SM
Ann Thorac Surg; 2008 May; 85(5):1651-5. PubMed ID: 18442558
[TBL] [Abstract][Full Text] [Related]
14. Cardiac surgery in a patient with heparin-induced thrombocytopenia--cautions with use of the direct thrombin inhibitor, argatroban.
Kurup V; Transue S; Wu Y; Rinder HM; Barash P; Dewar M
Conn Med; 2006 Apr; 70(4):245-50. PubMed ID: 16768071
[TBL] [Abstract][Full Text] [Related]
15. [Open heart surgery using cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia(HIT)].
Furukawa H; Konishi T; Fukata M; Okada H; Sakagami N; Kurosaki K
Kyobu Geka; 2013 May; 66(5):383-6. PubMed ID: 23674036
[TBL] [Abstract][Full Text] [Related]
16. Use of an argatroban-based purge solution in a percutaneous ventricular assist device.
Laliberte B; Reed BN
Am J Health Syst Pharm; 2017 May; 74(9):e163-e169. PubMed ID: 28438820
[TBL] [Abstract][Full Text] [Related]
17. Application of argatroban, direct thrombin inhibitor, in heparin-intolerant patients requiring extracorporeal circulation.
Matsuo T; Koide M; Kario K
Artif Organs; 1997 Sep; 21(9):1035-8. PubMed ID: 9288875
[TBL] [Abstract][Full Text] [Related]
18. Systemic infusion and local irrigation with argatroban effective in preventing clot formation during carotid endarterectomy in a patient with heparin-induced thrombocytopenia.
Serrone JC; Andaluz N; Brink V; Zuccarello M; Ware SL
World Neurosurg; 2013; 80(1-2):222.e15-8. PubMed ID: 23321376
[TBL] [Abstract][Full Text] [Related]
19. Activated protein C resistance and lupus anticoagulant in pregnancy.
Busowski JD; Jenkins AD; Hale EU; Busowski M; Dacus JV
J Matern Fetal Med; 1999; 8(6):298-9. PubMed ID: 10582865
[TBL] [Abstract][Full Text] [Related]
20. Obstinate thrombosis during percutaneous coronary intervention in a case with heparin-induced thrombocytopenia with thrombosis syndrome successfully treated by argatroban anticoagulant therapy.
Sakai K; Oda H; Honsako A; Takahashi K; Miida T; Higuma N
Catheter Cardiovasc Interv; 2003 Jul; 59(3):351-4. PubMed ID: 12822157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
